- 2013
-
Press releases - 07.03.2013
Launch of Constances, the largest epidemiological cohort study of the French population
Constances is a “generalist’ epidemiological cohort constituted from a representative sample of 200,000 adults aged 18 to 69. It has been organised by the Centre de recherche en épidémiologie et santé des populations (CESP – INSERM/Université Paris Sud/Université de Versailles Saint-Quentin-en-Yvelines) in partnership .
-
What's on? - 05.03.2013
Cerebro: a new application for exploring the brain
For the first time, you can convert your tablets and smartphones into a tool for exploring the brain so as to better understand and prevent strokes (the third-greatest cause of death). On the occasion of Brain Week that was held from 11 to 17 March 2013, Cérébro, a new application was launched on the Iphone […]
-
Press releases - 05.03.2013
Seven genetic risk factors associated with AMD
An international group of researchers has discovered seven new regions in the human genome associated with an increased risk of developing age-related macular degeneration (AMD), one of the main causes of blindness.
-
Press releases - 28.02.2013
(French) : GrippeNet.fr : bilan au pic de l’épidémie
Le 27 février, les données de la surveillance de la grippe confirmaient le franchissement du pic épidémique de la grippe saisonnière. Le site Internet www.grippenet.fr permet pour la deuxième année consécutive de collecter des données sur les syndromes grippaux directement auprès de la population française.
-
Press releases - 28.02.2013
When hypertension progresses unseen
When blood pressure is normal in the doctor’s surgery, but is high at home! This is an unknown phenomenon known as “masked hypertension”. Christophe Tzourio, Research Director of Inserm unit 708 “Neuroepidemiology” (University of Bordeaux Ségalen) studied the occurrence of masked hypertension in a population of 1500 elderly persons.
-
News in brief - 27.02.2013
NanoAthero: using nanomedicine to treat cardiovascular diseases
Sixteen partners from 10 European countries got together to create the “Nanomedicine for Atherosclerosis” consortium. Its aim is to study and develop the clinical feasibility of nanomedicine for targeted diagnosis and treatment of atherosclerosis. Coordinated by Inserm, the project has just obtaining funding amounting to 10 million euros over five years from the European Commission. […]
-
What's on? - 27.02.2013
28 February: international rare diseases day
Rare diseases currently affect fewer than one in 2000 people. There are 8,000 such diseases in the world, and five new ones are identified every month. They are generally genetic conditions, but also include auto-immune diseases, infectious diseases, cancers, etc. The Sixth International Day of Rare Diseases was held on Thursday 28 February in more […]
-
Press releases - 27.02.2013
André Syrota reappointed as Inserm Chairman and CEO
André Syrota has been reappointed by the French government as Chairman and CEO of the National Institute of Health and Medical Research (Inserm), on the recommendation of the Minister for Higher Education and Research, Geneviève Fioraso.
-
Press releases - 26.02.2013
Treatment with HDL cholesterol to aid thrombolysis
Research performed by the Neurology Department and Stroke Reception and Treatment Unit at the Bichat Hospital (AP-HP/ Paris University Diderot) and the associated INSERM Unit 698 (Prof. Amarenco, Dr Olivier Meilhac) has highlighted the benefits of good cholesterol in reducing bleeding complications in the only treatment available for embolic stroke. The results of this experiment, performed on the rat, have just been published in Stroke .
-
What's on? - 26.02.2013
Study of the consumption of food supplements
Very little information is currently available in France about the consumption of food supplements and the associated behavioural factors, in particular in population groups such as smokers for whom, according to researchers, the taking of certain supplements could represent an increased risk in relation to certain diseases. The relative proportion of people who are self-medicating […]